Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
NCT00777244
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Adrenocortical Carcinoma
Interventions
DRUG:
MITOTANE
Sponsor
University of Turin, Italy